Table 1. Subject characteristics of 30 cases with cataract and PHPV at clinical presentation.
| Case/No. | Eye | Gender | Age (mo) | Eye | Diagnosis | Axial length (mm) | Surgical treatment | Preop. UCVA (logMAR) | Postop. UCVA (logMAR) | BCVA at final follow up (logMAR) |
| 1 | 1 | F | 4 | OS | cata+aPHPV | 18.92 | Phaco+dia+aV+2°IOL | Unmeasurable | CF | CF |
| 2 | 2 | M | 36 | OS | cata+aPHPV | 22.01 | Phaco+dia+aV+IOL | 1.10 | 0.52 | 0.30 |
| 3 | 3 | M | 48 | OD | cata+aPHPV | 23.11 | Phaco+dia+aV+IOL | 1.0 | 0.30 | 0.22 |
| 4 | 4 | F | 36 | OD | cata+aPHPV | 21.91 | Phaco+dia+aV+IOL | 1.70 | 0.52 | 0.30 |
| 5 | 5 | M | 60 | OU | cata+aPHPV | 22.01 | Phaco+dia+aV+IOL | 0.92 | 0.40 | 0.30 |
| 5 | 6 | M | 60 | OU | cata+aPHPV | 21.01 | Phaco+dia+aV+IOL | 0.82 | 0.30 | 0.22 |
| 6 | 7 | M | 6 | OD | cata+aPHPV | 20.09 | Phaco+dia+aV+2° IOL | Unmeasurable | 0.52 | 0.30 |
| 7 | 8 | F | 48 | OD | cata+aPHPV | 22.80 | Phaco+dia+aV+IOL | 1.0 | 0.60 | 0.22 |
| 8 | 9 | F | 12 | OD | cata+aPHPV | 21.90 | Phaco+dia+aV+2° IOL | Unmeasurable | 0.40 | 0.30 |
| 9 | 10 | M | 36 | OD | cata+pPHPV | 21.06 | Phaco+pV+ RP+IOL | 1.30 | 0.52 | 0.40 |
| 10 | 11 | M | 96 | OD | cata+pPHPV | 22.09 | Phaco+pV+ RP+IOL | 1.70 | 0.00 | 0.00 |
| 11 | 12 | M | 96 | OS | cata+pPHPV | 22.30 | Phaco+pV+RP+IOL | HM | 0.60 | 0.40 |
| 12 | 13 | M | 120 | OS | cata+pPHPV | 19.07 | Phaco+pV+RP+IOL | HM | CF | 0.30 |
| 13 | 14 | F | 36 | OS | cata+pPHPV | 23.62 | Phaco+pV+RP+IOL | 1.70 | 0.82 | 0.52 |
| 14 | 15 | F | 60 | OS | cata+pPHPV | 21.98 | Phaco+pV+RP+IOL | 1.00 | 0.60 | 0.40 |
| 15 | 16 | M | 24 | OS | MGS+pPHPV | 22.00 | Phaco+pV+2° IOL | Unmeasurable | 0.92 | 0.52 |
| 16 | 17 | F | 5 | OU | cata+pPHPV | 20.87 | Phaco+pV+2° IOL | 1.00 | 0.52 | 0.30 |
| 16 | 18 | F | 5 | OU | cata+pPHPV | 20.01 | Phaco+pV+2° IOL | 0.92 | 0.40 | 0.40 |
| 17 | 19 | M | 5 | OU | cata+pPHPV | 20.10 | Phaco+pV+2° IOL | 1.10 | 0.92 | 0.52 |
| 17 | 20 | M | 5 | OU | pPHPV+microphthalmia | 16.76 | Phaco+pV+2° IOL | 1.00 | 0.82 | 0.40 |
| 18 | 21 | M | 6 | OD | cata+pPHPV | 20.90 | Phaco+pV+2° IOL | Unmeasurable | 0.40 | 0.30 |
| 19 | 22 | M | 3 | OD | cata+pPHPV | 21.80 | Phaco+pV+2° IOL | Unmeasurable | 0.60 | 0.40 |
| 20 | 23 | F | 96 | OS | cata+pPHPV | 22.30 | Phaco+pV+RP+oil+2° oil removal with IOL | HM | 1.10 | 0.40 |
| 21 | 24 | M | 108 | OS | cata+pPHPV | 21.54 | Phaco+pV+RP+oil+2° oil removal with IOL | 1.00 | 0.00 | 0.00 |
| 22 | 25 | M | 30 | OS | cata+pPHPV | 17.27 | Phaco+pV+RP+oil+2° oil removal with IOL | 1.00 | 0.60 | 0.40 |
| 23 | 26 | F | 48 | OD | cata+pPHPV | 21.09 | Phaco+pV+RP+oil+2° oil removal with IOL | 1.10 | 0.22 | 0.22 |
| 24 | 27 | M | 84 | OS | cata+pPHPV | 19.00 | Phaco+pV+RP+oil | LP | CF | CF |
| 25 | 28 | M | 48 | OS | cata+pPHPV | 21.45 | Phaco+pV+RP+oil | CF | CF | CF |
| 26 | 29 | M | 6 | OS | cata+pPHPV | 20.00 | Phaco+pV (no IOL) | Unmeasurable | Grabs objects | Grabs objects |
| 27 | 30 | F | 3 | OD | cata+pPHPV | 19.01 | Phaco+pV (no IOL) | Unmeasurable | Grabs objects | Grabs objects |
| 28 | 31 | F | 3 | OS | cata+pPHPV | 18.98 | Phaco+pV (no IOL) | Unmeasurable | Grabs objects | Grabs objects |
| 29 | 32 | F | 3 | OD | cata+pPHPV | 18.92 | Phaco+pV (no IOL) | Unmeasurable | Grabs objects | Grabs objects |
| 30 | 33 | M | 60 | OS | cata+pPHPV+microphthalmia | 14.76 | Untreated | - | - | - |
UCVA: Uncorrected visual acuity; BCVA: Best-corrected visual acuity; cata: Cataract; aPHPV: Anterior persistent hyperplastic primary vitreous; Phaco: Phacoemulsification; dia: Diathermy; aV: Anterior vitrectomy; 2° IOL: IOL implanted in a second procedure; CF: Count fingers; pPHPV: Posterior persistent hyperplastic primary vitreous; pV: Posterior vitrectomy; RP: Retinal photocoagulation; HM: Hand movement; MGS: Morning glory syndrome; oil: Silicone oil.